Early Access — free while we kick the tires
EdgarHawk

Buchholz Richard

Chief Financial Officer

Director Officer
3 filings analyzed · 2 companies · Latest 2026-03-17

Companies

Company Buys Sells Direction
SHOULDER INNOVATIONS, INC. SI 3 0 Net buying
Inspire Medical Systems, Inc. INSP 0 1 Net selling

Activity

March 2026
medium
Buy
1,000 shares
$14,840
Significance 4/10

Director Buchholz buys 1.0K shares of SI at $14.84; holds 13.7K post-transaction. Company unprofitable but revenue up 49.6% YoY.

Buchholz purchased 1,000 shares at $14.84 on 2026-03-13, increasing his holdings to 13.7K shares (a +7.9% increase). The company is currently unprofitable with net income of $-8.7M against revenue of $11.8M, though annual revenue growth was +49.6%. Buchholz's prior buy at this same ticker on 2025-08-01 returned -20.7% over 90 days, establishing a pattern of poorly-timed purchases at SI; this new buy occurs as the stock trades at -7.8% from its 52-week high despite a +15.8% 30-day gain. The presence of 2 other insider buys within 14 days suggests coordinated director-level interest, though Buchholz's prior trading history at this ticker does not support confidence in the timing.

September 2025
high
Sell
11,000 shares
$1,027,290
Significance 6/10

CFO Buchholz sold 11,000 INSP shares at $93.39; stock down 56.4% from 52-week high, he's now down to 44,867 shares held

Buchholz sold 11,000 shares at $93.39, reducing his position by 19.7% to 44,867 shares post-transaction. The timing is notable: his prior sell at INSP on 2024-04-17 posted a 90-day return of -36.6%, representing a well-timed exit, and this new sale occurs as the stock has fallen 25.0% over the last 30 days and 31.5% over 90 days from elevated levels ($216.71 52-week high). Current price of $94.51 sits 56.4% below that high, suggesting material deterioration in valuation since peak. The company posted net income of $-3,592,000.00 in the latest quarter despite revenue growth of 28.5% year-over-year, indicating profitability challenges beneath top-line expansion. The prior INSP transaction's favorable timing pattern—where the stock subsequently declined—provides historical context for evaluating whether the insider again anticipated downside.

August 2025
high
Buy
5,000 shares
$75,000
Significance 7/10

Director Buchholz bought 5,000 shares of SI at $15.00 (+65.2% holdings increase); 6 other insiders bought in past 14 days.

Richard Buchholz, a director of Shoulder Innovations, purchased 5,000 shares at $15.00 on 2025-08-01, increasing his holdings from 7,666 shares to 12,666 shares—a 65.2% increase in position size. This activity occurs in a cluster pattern: 6 other insiders have also bought within the past 14 days, suggesting coordinated confidence in the company shortly after its recent listing (4 trading days as of the price snapshot). The current price of $14.16 sits slightly below the transaction price, placing the purchase near recent trading levels. The concentration of director-level buying activity across multiple insiders within a tight timeframe warrants investor attention to understand the fundamental drivers behind this coordinated accumulation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access